{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:23:27Z","timestamp":1791357807848,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006785","name":"Google","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY029885"],"award-info":[{"award-number":["EY029885"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY033831"],"award-info":[{"award-number":["EY033831"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ophtha.2023.12.031","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T11:44:39Z","timestamp":1703850279000},"page":"645-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Short-term Detection of Fast Progressors in Glaucoma"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-2720","authenticated-orcid":false,"given":"Felipe A.","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davina A.","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-6602","authenticated-orcid":false,"given":"Swarup S.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2506-7095","authenticated-orcid":false,"given":"Michael V.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-5797","authenticated-orcid":false,"given":"David S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-8353","authenticated-orcid":false,"given":"Alessandro A.","family":"Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.12.031_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2023.12.031_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.4.2.1","article-title":"Why do people (still) go blind from glaucoma?","volume":"4","author":"Susanna","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib3","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.12.031_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1167\/iovs.13-13006","article-title":"Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime","volume":"55","author":"Saunders","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.12.031_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2020.05.019","article-title":"Rates of glaucomatous structural and functional change from a large clinical population: The Duke Glaucoma Registry Study","volume":"222","author":"Jammal","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib7","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.ophtha.2019.07.023","article-title":"Corneal biomechanics and visual field progression in eyes with seemingly well-controlled intraocular pressure","volume":"126","author":"Susanna","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2018.06.017","article-title":"Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 studies","volume":"125","author":"Weinreb","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/01621459.1965.10480784","article-title":"Design for optimal prediction in simple linear regression","volume":"60","author":"Gaylor","year":"1965","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.ophtha.2023.12.031_bib10","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1167\/iovs.12-9476","article-title":"Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach","volume":"53","author":"Crabb","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.12.031_bib11","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1038\/s41598-018-23220-w","article-title":"Impact of different visual field testing paradigms on sample size requirements for glaucoma clinical trials","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ophtha.2023.12.031_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55345-x","article-title":"Sample size requirements of glaucoma clinical trials when using combined optical coherence tomography and visual field endpoints","volume":"9","author":"Wu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ophtha.2023.12.031_bib13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2023.12.031_bib14","series-title":"Econometric Analysis of Cross Section and Panel Data","author":"Wooldridge","year":"2002"},{"key":"10.1016\/j.ophtha.2023.12.031_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2017.06.017","article-title":"Impact of normal aging and progression definitions on the specificity of detecting retinal nerve fiber layer thinning","volume":"181","author":"Wu","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ogla.2020.05.006","article-title":"Using the rate of glaucomatous visual field progression in one eye to help assess the rate in the fellow eye","volume":"3","author":"Anderson","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ophtha.2023.12.031_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ajo.2013.06.017","article-title":"Likelihood ratios for glaucoma diagnosis using spectral-domain optical coherence tomography","volume":"156","author":"Lisboa","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.1994.03510290071040","article-title":"Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2023.12.031_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","article-title":"Likelihood ratios with confidence: sample size estimation for diagnostic test studies","volume":"44","author":"Simel","year":"1991","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.2.16","article-title":"Rates of glaucoma progression derived from linear mixed models using varied random effect distributions","volume":"11","author":"Swaminathan","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib22","doi-asserted-by":"crossref","first-page":"OCT421","DOI":"10.1167\/iovs.15-18940","article-title":"The relative odds of progressing by structural and functional tests in glaucoma","volume":"57","author":"Abe","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.12.031_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.preteyeres.2004.10.002","article-title":"Longitudinal changes in the visual field and optic disc in glaucoma","volume":"24","author":"Artes","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2023.12.031_bib24","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1167\/iovs.12-10345","article-title":"The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change","volume":"53","author":"Medeiros","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.12.031_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma","volume":"156","author":"Peters","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ophtha.2017.01.027","article-title":"Frequency of testing to detect visual field progression derived using a longitudinal cohort of glaucoma patients","volume":"124","author":"Wu","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archophthalmol.2010.196","article-title":"Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change","volume":"128","author":"Chauhan","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ophtha.2022.12.025","article-title":"Validation of rates of mean deviation change as clinically relevant end points for glaucoma progression","volume":"130","author":"Medeiros","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamaophthalmol.2016.1659","article-title":"Association of fast visual field loss with risk of falling in patients with glaucoma","volume":"134","author":"Baig","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","article-title":"Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study","volume":"115","author":"McKean-Cowdin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ophtha.2014.08.014","article-title":"Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients","volume":"122","author":"Medeiros","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.12.031_bib33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaophthalmol.2014.5319","article-title":"Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma","volume":"133","author":"Gracitelli","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.12.031_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1167\/iovs.10-5174","article-title":"A\u00a0comparison of functional and structural measures for identifying progression of glaucoma","volume":"52","author":"Xin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023009387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023009387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:53:55Z","timestamp":1777492435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023009387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0161642023009387"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.031","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term Detection of Fast Progressors in Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}